Chimera Inv Financials
This page shows Chimera Inv (CIMP) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 18 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Financial Health Signals
Based on FY2025 annual data, averaged across the last 3 years for performance metrics (most-recent year weighted highest). How this score is calculated →
Health score ≠ stock price. This rates the quality of Chimera Inv's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.
Chimera Inv carries a low D/E ratio of 0.10, meaning only $0.10 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 100/100, indicating a strong balance sheet with room for future borrowing.
Chimera Inv generates a 9.0% ROE, indicating limited profit relative to shareholders' investment. This results in a returns score of 28/100. This is up from 7.0% the prior year.
Chimera Inv passes 2 of 9 financial strength tests. 2 of 4 profitability signals pass, no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution).
For every $1 of reported earnings, Chimera Inv generates $-1.08 in operating cash flow (-$248.9M OCF vs $230.5M net income). This low ratio suggests earnings are primarily driven by accounting accruals rather than cash generation, which may not be sustainable.
Key Financial Metrics
Earnings & Revenue
Chimera Inv reported $230.5M in net income in fiscal year 2025. This represents an increase of 30.9% from the prior year.
Chimera Inv earned $1.72 per diluted share (EPS) in fiscal year 2025. This represents an increase of 56.4% from the prior year.
Cash & Balance Sheet
Chimera Inv held $278.6M in cash against $251.5M in long-term debt as of fiscal year 2025.
Chimera Inv paid $1.48 per share in dividends in fiscal year 2025. This represents an increase of 4.2% from the prior year.
Chimera Inv had 83M shares outstanding in fiscal year 2025. This represents an increase of 3.1% from the prior year.
Margins & Returns
Chimera Inv's ROE was 9.0% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is up 2.0 percentage points from the prior year.
Capital Allocation
Chimera Inv spent $0 on share buybacks in fiscal year 2025, returning capital to shareholders by reducing shares outstanding.
CIMP Income Statement
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 |
|---|---|---|---|---|---|---|---|---|
| Revenue | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Cost of Revenue | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Gross Profit | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| R&D Expenses | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| SG&A Expenses | $12.2M+30.2% | $9.3M+34.6% | $6.9M+1.8% | $6.8M-1.3% | $6.9M+23.4% | $5.6M-0.2% | $5.6M-10.6% | $6.3M |
| Operating Income | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Interest Expense | $144.3M-6.4% | $154.2M+7.0% | $144.1M+6.5% | $135.3M+11.4% | $121.4M-4.1% | $126.5M-1.8% | $128.8M+7.9% | $119.4M |
| Income Tax | -$2.1M | N/A | $251K-38.6% | $409K-76.7% | $1.8M | N/A | $16K-48.4% | $31K |
| Net Income | -$43.9M-255.0% | $28.3M+4984.8% | -$580K-101.6% | $35.5M-78.8% | $167.3M+214.2% | -$146.5M-207.4% | $136.5M+140.8% | $56.7M |
| EPS (Diluted) | $-0.78 | N/A | $-0.27-258.8% | $0.17-90.4% | $1.77 | N/A | $1.39+239.0% | $0.41 |
CIMP Balance Sheet
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $16.0B+1.1% | $15.8B+4.6% | $15.1B+1.7% | $14.9B+12.6% | $13.2B+0.7% | $13.1B-4.3% | $13.7B+4.3% | $13.1B |
| Current Assets | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Cash & Equivalents | $476.2M+70.9% | $278.6M-43.3% | $491.5M+96.4% | $250.2M-1.2% | $253.3M+201.6% | $84.0M-13.7% | $97.3M-40.0% | $162.3M |
| Inventory | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Accounts Receivable | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Goodwill | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Liabilities | $13.5B+2.1% | $13.2B+5.5% | $12.5B+2.5% | $12.2B+15.9% | $10.6B-0.3% | $10.6B-3.4% | $11.0B+4.5% | $10.5B |
| Current Liabilities | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Long-Term Debt | $252.0M+0.2% | $251.5M+0.2% | $251.0M+85.6% | $135.2M+0.2% | $134.9M+0.2% | $134.6M+0.2% | $134.4M+115.4% | $62.4M |
| Total Equity | $2.5B-4.2% | $2.6B+0.1% | $2.6B-2.0% | $2.6B-0.7% | $2.6B+4.7% | $2.5B-7.7% | $2.7B+3.6% | $2.6B |
| Retained Earnings | $4.5B-1.0% | $4.6B+0.6% | $4.5B0.0% | $4.5B+0.8% | $4.5B+3.9% | $4.3B-3.3% | $4.5B+3.1% | $4.4B |
CIMP Cash Flow Statement
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $243.3M+259.3% | -$152.8M-11.1% | -$137.5M-1750.5% | -$7.4M-115.2% | $48.8M+28.6% | $38.0M-8.4% | $41.4M-40.0% | $69.0M |
| Capital Expenditures | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Investing Cash Flow | $355.7M+205.5% | -$337.0M-679.7% | $58.1M+104.8% | -$1.2B-586.1% | -$175.3M-125.4% | $689.7M+206.7% | -$646.2M-469.1% | -$113.5M |
| Financing Cash Flow | -$400.5M-241.6% | $282.8M-11.8% | $320.6M-73.4% | $1.2B+308.0% | $295.9M+139.9% | -$740.9M-237.3% | $539.8M+1325.9% | $37.9M |
| Dividends Paid | $32.4M+1.4% | $31.9M+6.3% | $30.0M-0.7% | $30.2M-1.2% | $30.6M+1.6% | $30.1M-13.8% | $34.9M+28.3% | $27.2M |
| Share Buybacks | N/A | N/A | N/A | N/A | N/A | $0 | $0 | N/A |
CIMP Financial Ratios
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Return on Equity | -1.8%-2.9pp | 1.1%+1.1pp | -0.0%-1.4pp | 1.4%-5.0pp | 6.3%+12.1pp | -5.8%-10.8pp | 5.0%+2.8pp | 2.1% |
| Return on Assets | -0.3%-0.5pp | 0.2%+0.2pp | 0.0%-0.2pp | 0.2%-1.0pp | 1.3%+2.4pp | -1.1%-2.1pp | 1.0%+0.6pp | 0.4% |
| Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Debt-to-Equity | 0.100.0 | 0.100.0 | 0.10+0.0 | 0.050.0 | 0.050.0 | 0.050.0 | 0.05+0.0 | 0.02 |
| FCF Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Frequently Asked Questions
Is Chimera Inv profitable?
Yes, Chimera Inv (CIMP) reported a net income of $230.5M in fiscal year 2025.
How much debt does Chimera Inv have?
As of fiscal year 2025, Chimera Inv (CIMP) had $278.6M in cash and equivalents against $251.5M in long-term debt.
Does Chimera Inv pay dividends?
Yes, Chimera Inv (CIMP) paid $1.48 per share in dividends during fiscal year 2025.
What is Chimera Inv's return on equity (ROE)?
Chimera Inv (CIMP) has a return on equity of 9.0% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.
What is Chimera Inv's operating cash flow?
Chimera Inv (CIMP) generated -$248.9M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.
What are Chimera Inv's total assets?
Chimera Inv (CIMP) had $15.8B in total assets as of fiscal year 2025, including both current and long-term assets.
What is Chimera Inv's debt-to-equity ratio?
Chimera Inv (CIMP) had a debt-to-equity ratio of 0.10 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is Chimera Inv's return on assets (ROA)?
Chimera Inv (CIMP) had a return on assets of 1.5% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
What is Chimera Inv's cash runway?
Based on fiscal year 2025 data, Chimera Inv (CIMP) had $278.6M in cash against an annual operating cash burn of $248.9M. This gives an estimated cash runway of approximately 13 months at the current burn rate. Cash runway measures how long a company can continue operating before running out of cash, assuming no additional funding.
What is Chimera Inv's Piotroski F-Score?
Chimera Inv (CIMP) has a Piotroski F-Score of 2 out of 9, indicating weak financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are Chimera Inv's earnings high quality?
Chimera Inv (CIMP) has an earnings quality ratio of -1.08x, considered low quality (accrual-driven). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
How financially healthy is Chimera Inv?
Chimera Inv (CIMP) scores 21 out of 100 on our Financial Profile, indicating weak overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.